World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02544490
Date of registration: 29/08/2015
Prospective Registration: No
Primary sponsor: National University Hospital, Singapore
Public title: Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis miRNA-Sepsis
Scientific title: Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis
Date of first enrolment: September 2013
Target sample size: 450
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02544490
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Singapore
Contacts
Name:     Win Sen Kuan, MBBS
Address: 
Telephone:
Email:
Affiliation:  National University Hospital, Singapore
Key inclusion & exclusion criteria

Inclusion criteria for controls:

- Adults 21 years and above

- Has condition unrelated to any infective cause

Exclusion criteria for controls:

- Underlying chronic inflammatory condition (e.g. inflammatory bowel disease)

- Underlying autoimmune disease (e.g. rheumatoid arthritis, systemic lupus
erythematosus)

- Pre-existent immunological disorder

Inclusion criteria for subjects:

- Adults 21 years and above

- Clinical/radiological suspicion or confirmation of infection

Exclusion criteria for subjects:

- Age below 21 years

- Prisoners

- Known pregnancy

- Do-not-attempt resuscitation status

- Requirement for immediate surgery

- Active chemotherapy

- Hematological malignancy

- Treating physician deems aggressive care unsuitable

- Unable to provide informed consent or comply with study requirements



Age minimum: 21 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Sepsis
Intervention(s)
Primary Outcome(s)
Fold changes of miRNA expression [Time Frame: 3 years]
Secondary Outcome(s)
MiRNA panel test performance metrics [Time Frame: 3 years]
Secondary ID(s)
TA/0029/2014
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
A*Star
MiRXES Pte Ltd
National University, Singapore
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history